Evidence map›Paper›PMID 29555899›Full record

ArticleNature communications2018

Biomimetic artificial organelles with in vitro and in vivo activity triggered by reduction in microenvironment.

T Einfalt, D Witzigmann, C Edlinger, S Sieber, R Goers, A Najer, M Spulber, O Onaca-Fischer, J Huwyler, C G Palivan

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Review
  3. Multiphysics-Driven Assembly of Biomimetic Vesicles.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Photoreceptor-Like Signal Transduction Between Polymer-Based Protocells.Advanced materials (Deerfield Beach, Fla.) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Synthetic Cells Revisited: Artificial Cells Construction Using Polymeric Building Blocks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T EinfaltDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
D WitzigmannDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, CH-4056, Basel, Switzerland.
C EdlingerDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
S SieberDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, CH-4056, Basel, Switzerland.
R GoersDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
A NajerDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
M SpulberDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
O Onaca-FischerDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland.
J HuwylerDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, CH-4056, Basel, Switzerland.
C G PalivanDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056, Basel, Switzerland. Cornelia.Palivan@unibas.ch.ORCID http://orcid.org/0000-0001-7777-5355
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite tremendous efforts to develop stimuli-responsive enzyme delivery systems, their efficacy has been mostly limited to in vitro applications. Here we introduce, by using an approach of combining biomolecules with artificial compartments, a biomimetic strategy to create artificial organelles (AOs) as cellular implants, with endogenous stimuli-triggered enzymatic activity. AOs are produced by inserting protein gates in the membrane of polymersomes containing horseradish peroxidase enzymes selected as a model for natures own enzymes involved in the redox homoeostasis. The inserted protein gates are engineered by attaching molecular caps to genetically modified channel porins in order to induce redox-responsive control of the molecular flow through the membrane. AOs preserve their structure and are activated by intracellular glutathione levels in vitro. Importantly, our biomimetic AOs are functional in vivo in zebrafish embryos, which demonstrates the feasibility of using AOs as cellular implants in living organisms. This opens new perspectives for patient-oriented protein therapy.

Indexed as

Biomimetic MaterialsAmino Acid SubstitutionAnimalsArtificial CellsBiocatalysisBioengineeringBiomimeticsCellular MicroenvironmentHeLa CellsHumansOrganellesPorinsRecombinant ProteinsZebrafishOmpF proteinPorinsRecombinant Proteins

Identifiers

PMID29555899
PMCPMC5859287
OpenAlexW2793945018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.